Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · IEX Real-Time Price · USD
0.131
-0.001 (-0.53%)
Sep 28, 2023, 9:57 AM EDT - Market open
MTNB Market Cap
MTNB has a market cap or net worth of $28.70 million as of September 28, 2023. Its market cap has decreased by -79.94% in one year.
Market Cap
28.70M
Enterprise Value
9.90M
1-Year Change
-79.94%
Ranking
Category
Stock Price
$0.13
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $28.70M, a decrease of -87.16%. That is a compound annual growth rate of -26.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 27, 2023 | 28.70M | -6.21% |
Sep 26, 2023 | 30.60M | 12.50% |
Sep 25, 2023 | 27.20M | -6.53% |
Sep 22, 2023 | 29.10M | 3.19% |
Sep 21, 2023 | 28.20M | -5.37% |
Sep 20, 2023 | 29.80M | - |
Sep 19, 2023 | 29.80M | -6.58% |
Sep 18, 2023 | 31.90M | 13.12% |
Sep 15, 2023 | 28.20M | -15.82% |
Sep 14, 2023 | 33.50M | -3.74% |
Sep 13, 2023 | 34.80M | -2.79% |
Sep 12, 2023 | 35.80M | 4.99% |
Sep 11, 2023 | 34.10M | -3.67% |
Sep 8, 2023 | 35.40M | 0.57% |
Sep 7, 2023 | 35.20M | 1.15% |
Sep 6, 2023 | 34.80M | -5.18% |
Sep 5, 2023 | 36.70M | -2.39% |
Sep 1, 2023 | 37.60M | -3.84% |
Aug 31, 2023 | 39.10M | -2.25% |
Aug 30, 2023 | 40.00M | -4.08% |
Aug 29, 2023 | 41.70M | 9.16% |
Aug 28, 2023 | 38.20M | -11.16% |
Aug 25, 2023 | 43.00M | 5.39% |
Aug 24, 2023 | 40.80M | -0.73% |
Aug 23, 2023 | 41.10M | 18.10% |
View and export this data all the way back to 2017.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAB Biotherapeutics | 27.78M |
Coeptis Therapeutics | 27.67M |
Liminal BioSciences | 27.62M |
Elevation Oncology | 27.55M |
Qilian International Holding Group | 27.54M |
Enlivex Therapeutics | 27.15M |
Corbus Pharmaceuticals Holdings | 26.81M |
CASI Pharmaceuticals | 26.64M |